Deka Bank Deutsche Girozentrale Seres Therapeutics, Inc. Transaction History

Deka Bank Deutsche Girozentrale

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$2.7 - $7.62 $180,900 - $510,540	-67,000 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$6.02 - $11.43 $12,040 - $22,860	2,000 Added 3.08%	67,000 $577,000
Q1 2021 Apr 28, 2021	BUY	$17.66 - $28.92 $1.15 Million - $1.88 Million	65,000 New	65,000 $1.25 Million
Q3 2019 Nov 14, 2019	SELL	$2.29 - $4.16 $74,654 - $135,616	-32,600 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$2.28 - $7.35 $29,183 - $94,080	12,800 Added 64.65%	32,600 $94,000

Q1 2019 May 10, 2019	BUY	$4.83 - $7.21 $16,905 - $25,235	3,500 Added 21.47%	19,800 $168,000
Q4 2018 Feb 12, 2019	SELL	$4.52 - $8.88 $15,819 - $31,080	-3,500 Reduced 17.68%	16,300 $75,000
Q1 2018 May 03, 2018	SELL	$7.34 - $11.16 $3,670 - $5,580	-500 Reduced 2.46%	19,800 $147,000
Q3 2017 Nov 06, 2017	BUY	$12.81 - $16.85 $260,043 - $342,055	20,300	20,300 $274,000

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.